Trials / Completed
CompletedNCT02915913
Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults
Effects of High Intensity Interval- vs Resistance or Combined- Training for Improving Cognitive Function and Neurotrophic Factors in Overweight Adults (BrainFit Study): Factorial Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Universidad Santo Tomas · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The BrainFit Study aims to examine acute effects of High Intensity Interval- vs Resistance or Combined program has benefits on Cognitive Function as well as on secretion and regulation of neurotrophic factors or neurotrophins in a cohort of sedentary, overweight adults (aged 18-30 years) from Bogota, Colombia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Experimental: High Intensity Interval | Walking on a treadmill 4min at 80-90% peak heart rate and recovery 4 min at 65% peak heart rate until expenditure of 500 kcal |
| BEHAVIORAL | Resistance training | Completing a resistance circuit (including upper and lower muscle groups) as many times as needed according to subject weight until expenditure of 500 kcal |
| BEHAVIORAL | Plus: High Intensity Interval + Resistance Training | Walking on a treadmill as intervention 1 until 50% the energy expenditure prescribed is reached, then completing a resistance circuit until 100% energy expenditure is reached |
| OTHER | Non-exercise | This group will receive the usual clinical care according to the consensus recommendations of the national goals for cardiovascular health promotion and disease reduction of the American Heart Association and Colombian guidelines COLDEPORTES. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-09-27
- Last updated
- 2018-10-11
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT02915913. Inclusion in this directory is not an endorsement.